selenium in tinnitus

Investigating the effect of using selenium in the treatment of tinnitus

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230417057946N1

Enrollment

Registered

2023-04-24

Start date

2023-05-22

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tinnitus. Tinnitus

Interventions

Intervention 1: Intervention group: treatment with selenium. In this group, patients are treated with 200 mg of selenium daily for up to 30 days. Selenium is prescribed in the form of a supplemental t

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 18 to 65 years old informed consent Complaint of tinnitus

Exclusion criteria

Exclusion criteria: Having psychiatric and/or cognitive disorders that prevent the understanding of tests and questionnaires. Using tinnitus-causing drugs Having any kind of hearing loss Patients with a history of diabetes and hypertension

Design outcomes

Primary

Measure	Time frame
Tinnitus severity. Timepoint: before the study beginning and one month after one month treatment. Method of measurement: tinnitus handicap inventory questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNiloofar Masomnia

Esfahan University of Medical Sciences

amnm_80@yahoo.com+98 31 3792 8134

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026